MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress » Parkinsonism, Atypical: MSA

Meeting: 2022 International Congress

A clinico-genetic study based on the Innsbruck MSA Registry

F. Leys, S. Eschlboeck, N. Campese, P. Mahlknecht, M. Peball, V. Sidoroff, R. Granata, V. Bonifati, J. Zschocke, S. Kiechl, W. Poewe, K. Seppi, GK. Wenning, A. Fanciulli (Innsbruck, Austria)

An automated AI-based framework for putamen volume measurement in MSA

M. Papoutsi, J. Weatheritt, M. Reinwald, I. Gidado, R. Joules, H. Kaufmann, I. Qureshi, R. Wolz (London, United Kingdom)

Association between sleep apnea and prognosis in patients with multiple system atrophy

S. Jo, S. Lee, J. Lee, SA. Lee, SJ. Chung (Seoul, Republic of Korea)

Cerebrospinal α-synuclein RT-QuIC in pathologically-confirmed Multiple System Atrophy

A. Symonds, G. Fairfoul, A. Green, D. Breen (Edinburgh, United Kingdom)

Cognitive performances and autonomic dysfunction in MSA patients

G. Lazzeri, A. Carandina, T. Di Fonzo, F. Arienti, E. Monfrini, I. Trezzi, G. Franco, E. Tobaldini, A. Di Fonzo (Milan, Italy)

Comorbid neuropathological features in multiple system atrophy

H. Sekiya, S. Koga, A. Murakami, D. Dickson (Jacksonville, USA)

Correlation of Voice parameters and Dysphagia Severity in Multiple System Atrophy

T. Hähnel, L. Berger, K. Schimming, A. Vogel, G. Ebersbach, B. Falkenburger, F. Gandor (Dresden, Germany)

Fever and syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine intake in patient with multiple system atrophy

J. Shi, L. Liu, J. Lin, M. Zhang, H. Liu, L. Xie (dalian, China)

Focused ultrasound offers tremor relief in multiple system atrophy patients

M. Nassar, A. Sinai, L. Shornikov, I. Erikh, M. Constantinescu, M. Zaaroor, I. Schlesinger (Haifa, Israel)

Gait and Balance Characteristics in Atypical Parkinsonian Syndromes

V. Sidoroff, C. Raccagni, K. Seppi, H. Gassner, J. Winkler, N. Hergenröder-Lenzner, N. Roth, B. Eskofier, S. Buechner, D. Benninger, K. Aminian, G. Wenning (Innsbruck, Austria)

Insights from skin biopsies: α-synuclein real-time quaking-induced conversion (RT-QuIC) in patients with Parkinson’s disease and multiple system atrophy

C. Panzer, J. Volkmann, C. Sommer, K. Doppler, A. Kuzkina (Würzburg, Germany)

It takes a village: An interdisciplinary care model for atypical Parkinsonism

H. Glover, J. Shurer, M. Ivancic, M. Sklerov (Chapel Hill, USA)

Mosaicism for somatic SNCA copy number variants in multiple system atrophy is related to pathological subtype and presence of α-synuclein inclusions

C. Proukakis, M. Garcia-Segura, D. Perez-Rodriguez, Z. Jaunmuktane (London, United Kingdom)

Multiple system atrophy mimicked by mitochondrial disease.

L. Diaz-Feliz, P. Garcia-Ruiz (Madrid, Spain)

Myelination relevant plasma microRNA biomarkers identified via an innovative data analytic scheme for differential diagnosis of MSA, an Oligodendroglial Synucleinopathy

CC. Lu, MC. Kuo, JW. Huang, Y-T. Tsai, H-H. Lin Wang, PJ. Kung, C-C. Wu, Y-Y. Hsueh, T. Ochiya, FKH. Phoa, S-P. Lin, R-M. Wu (Taipei, Taiwan)

Network Localisation of Multiple System Atrophy

E. Ellis, J. Joutsa, M. Fox, D. Corp (Melbourne, Australia)

Neurodegeneration and neuroinflammation for biomarker development in MSA

S. Katzdobler, F. Eckenweber, G. Nübling, L. Vogler, C. Palleis, S. Lindner, U. Fietzek, B. Nuscher, A. Mueller, N. Koglin, A. Stephens, C. Haass, M. Brendel, J. Levin (Munich, Germany)

Pons and middle cerebellar peduncle diameters are diagnostic of Multiple System Atrophy of the Cerebellar Type (MSA-C)

C. Stephen, M. Vangel, A. Gupta, J. Macmore, J. Schmahmann (Boston, USA)

Preliminary data on multimodal approach for early characterization of Parkinson’s disease (PD) and Multiple System Atrophy (MSA), a prospective study with connected insoles

F. Marchand, L. Farid, J. Labreuche, R. Viard, L. Defebvre, D. Devos, A. Mathieu, L. Kjaersgaard, AK. Berger, D. Meulien, V. Terebaite, JC. Brasen, C. Moreau (LILLE, France)

Prodromal non-motor symptoms in Multiple System Atrophy. Differences between cerebellar and parkinsonian phenotypes.

P. Millar Vernetti, H. Kaufmann, JA. Palma (New York, USA)

The Lion’s tail family: A Bavarian multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson’s disease with dementia

A. Fanciulli, F. Leys, F. Lehner, V. Sidoroff, V. Ruf, C. Raccagni, P. Mahlknecht, D. Kuipers, W. van Ijcken, H. Stockner, T. Musacchio, J. Volkmann, C. Monoranu, I. Stankovic, G. Breedveld, F. Ferraro, C. Fevga, O. Windl, J. Herms, S. Kiechl, W. Poewe, K. Seppi, N. Stefanova, S. Scholz, V. Bonifati, G. Wenning (Innsbruck, Austria)

The profile of dysautonomia in the early stages of Parkinson’s disease and multiple system atrophy: the importance of using the SCOPA-AUT scale

M. Jecmenica-Lukic, I. Stankovic, A. Tomic, N. Kresojevic, V. Markovic, I. Petrovic, N. Dragasevic, M. Svetel, V. Kostic (Belgrade, Serbia)

The study of clonidine growth hormone study amongst definite MSA, PD, PSP, and PAF patients to assess its feasibility as a future non-invasive biomarker

S. Bhattacharjee, E. Vichayanrat, L. Watson, V. Iodice (London, United Kingdom)

Tracking longitudinal changes in MSA: TALISMAN study protocol

W. Meissner, A. Varrone, A. Sahib, D. åström, J. Clarimon, A. Andreasen, A-K. Berger, J. Wiedemann, S. Sgarbi, D. Meulien (Pessac, France)

Wearable Sensors for Quantitative Motor Assessments in Multiple System Atrophy

D. Claassen, J. Iregui, A. Wynn, C. Davis, C. Wong, D. Stamler (Nashville, USA)

« View all sessions from the 2022 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley